AbbVie discusses drug pricing with the administration

AbbVie's CEO, Robert Michael, stated the company is encouraged by the administration's engagement regarding drug pricing policies during the Goldman Sachs Healthcare Conference. He noted productive conversations are ongoing. Michael highlighted discussions focusing on balancing medicine affordability and access with preserving a healthy innovation ecosystem. The company is navigating uncertainties in the pharmacy sector, particularly concerning drug pricing. The comments were made at the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025. AbbVie's executive team addressed policy-related uncertainties.